when a research project includes the collection of biological samples, all planned future uses of the samples, identifiers, and the data obtained from the samples, must be fully explained to the research subject.
When a research project collects biological samples, the rule you quoted is true : all reasonably foreseeable future uses of the samples, associated identifiers, and data obtained from those samples must be clearly explained to the research subject as part of informed consent.
What this statement really means
In plain language, it means:
- You cannot just say “we’ll keep your blood for research.”
- You must explain:
- What kinds of research the samples might be used for (e.g., genetic studies, future unspecified health research).
* Whether samples will be stored and for how long.
* Who might have access (e.g., other researchers, collaborating institutions, commercial partners).
* How identifiers will be handled (identifiable, coded, or de‑identified).
* What data will be derived from the samples (e.g., genomic data) and how it will be protected and possibly shared.
The core idea is respect for persons: participants should know what they are agreeing to and what might happen to parts of their body and related data in the future.
How this fits with “broad consent”
Modern ethics guidance allows what is often called broad consent :
- Participants give permission for a range of future research uses, not just a single narrowly defined study.
- Broad consent is considered ethically acceptable if:
- The initial consent clearly states future storage, sharing, and general types of research.
* There is an oversight process (e.g., an ethics board or biobank governance) that reviews proposed future studies.
* When feasible, donors can be informed over time or allowed to opt out of future uses.
So, you do not need to list every specific future project by name, but you do need to describe categories of use and the rules around them in a way a reasonable person can understand.
Practical example (mini story)
Imagine a study in 2026 collecting blood from volunteers to study diabetes:
- The consent form explains:
- Samples will be stored in a secure biobank for up to 20 years.
* They may be used in future research on metabolic, cardiovascular, and related conditions, possibly including genetic analyses.
* Samples will be coded (not directly identified), and only authorized researchers who obtain ethics approval can use them.
* Some results may be shared in databases in a de‑identified form.
- A participant signs, understanding that their blood might be used in later approved projects in those areas, even if those projects don’t exist yet.
This satisfies the idea that “all planned future uses” (in the sense of foreseeable categories and conditions) are fully explained to the subject, even though the exact future study titles are not yet known.
Key takeaways (bullet summary)
- Informed consent for biospecimens must cover:
- Storage and duration.
* Types of future research uses.
* Handling of identifiers and coding.
* Data generation, protection, and sharing.
- Broad consent is widely accepted if paired with governance and clear explanation.
- The sentence you provided reflects the ethical and regulatory expectation that donors are not left in the dark about what may happen to their samples and data.
Information gathered from public forums or data available on the internet and portrayed here.